Effective November 1, 2017, or as contract terms permit, Evonik will increase globally prices for all polyurethane additives. The increase will be 5-10% depending on product type including DABCO®, POLYCAT®, TEGOSTAB®, TEGOAMIN®, KOSMOS®, GORAPUR® release agents and ORTEGOL® products.
Stannous Octoate (KOSMOS® 29, DABCO® T9) will be dealt with separately.
Evonik has worked diligently and will continue working to offset continuously rising raw material, energy, labour and transportation costs, however it is not possible to absorb all of these rising cost. Evonik will increase polyurethane additive prices in order to continue to meet the needs of its customers in the future.
Evonik is one of the world leaders in specialty chemicals. The focus on more specialty businesses, customer-orientated innovative prowess and a trustful and performance-oriented corporate culture form the heart of Evonik’s corporate strategy. They are the lever for profitable growth and a sustained increase in the value of the company. Evonik benefits specifically from its customer proximity and leading market positions. Evonik is active in over 100 countries around the world with more than 35,000 employees.
About Nutrition & Care
The Nutrition & Care segment is led by Evonik Nutrition & Care GmbH and contributes to fulfilling basic human needs. That includes applications for everyday consumer goods as well as animal nutrition and health care. This segment employed about 7,500 employees, and generated sales of around
€4.3 billion in 2016.
In so far as forecasts or expectations are expressed in this press release or where our statements concern the future, these forecasts, expectations or statements may involve known or unknown risks and uncertainties. Actual results or developments may vary, depending on changes in the operating environment. Neither Evonik Industries AG nor its group companies assume an obligation to update the forecasts, expectations or statements contained in this release.